Tag Results for "USA"

George and Sonya were best friends who had been married for thirty-two years.  They lived an uncomplicated life in a rural area near Garner, NC.  But in January of 2010, everything changed when George's lung collapsed.  Test results revealed the worst: George was suffering from stage III small cell lung cancer. Like many Americans… More

For Calista G., nurturing comes very naturally; she has six children and twelve grandchildren, and she is a former worker in the childcare field. So, when she fell ill and became the one who needed care, it was hard for her to handle this role-reversal. During a routine self-exam, Calista noticed a lump in her left breast. Her doctor confirmed her… More

TEVA Pharmaceuticals USA and the National Cancer Coalition have partnered for the past decade to assist underserved patients in gaining access to the medicines that they require.  During this timeframe, NCC has received and then provided to our overseas partner hospitals over $75 million dollars worth of chemotherapy and adjunctive therapies… More

The NCC Provides relief program is providing required Factor VIII and Factor IX therapies to a number of special summer camps in the United States for children with hemophilia. It is estimated that over 1,000 children will attend these camps, and this new initiative will help several hundred underserved hemophiliac patients. The goal of this program… More

With cancer causing more deaths among children than any other disease in the United States, the National Cancer Coalition (NCC) is committed to equipping pediatric oncology researchers with the resources necessary to pursue innovative and alternative treatment options for children suffering with cancer. NCC, therefore, is proud to be providing highly… More

The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention… More